In a significant showcase for investors, BeOne Medicines announced major advancements to its industry-leading oncology ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

Indian drugmaker Biocon has announced that Health Canada has granted a Notice of Compliance for Yesafili (aflibercept), a ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...

Belgian pharma UCB today announced that the Phase III study investigating the safety and efficacy of adjunctive fenfluramine ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

Rising use of innovative medicines and shifting spending patterns are reshaping the global pharmaceutical landscape, ...

US biopharma company Altimmune saw its share slump almost 55% to $3.48 yesterday, after it announced what it called ‘positive ...

Despite calls for the meeting to be delayed, Wednesday’s meeting of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) went ahead.

US insurance giant Cigna has taken fresh legal action against Bristol Myers Squibb (NYSE: BMY), accusing the drugmaker of ...

The US Food and Drug Administration (FDA) has required and approved updates to the Prescribing Information for Comirnaty ...

Singapore-based biotech Hummingbird Bioscience has outlicensed its lead immunotherapy candidate, HMBD-002, to Australian drug ...